In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose

Ann Intern Med. 2021 Mar;174(3):JC28. doi: 10.7326/ACPJ202103160-028. Epub 2021 Mar 2.

Abstract

Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403-16. 33378609.

Publication types

  • Comment

MeSH terms

  • Adult
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • RNA, Messenger
  • SARS-CoV-2
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • Vaccines